Neurokappa Therapeutics

Business Data, Corporate Office and Headquarter Address

About

Neurokappa Therapeutics is Pharmaceuticals in United States that focus on drug substance business. Founded in 2015. They cover business area such as developer, manufacturer, cerebral vasospasm, subarachnoid hemorrhage, its short-live psychotropic effect.

Business Type

Pharmaceuticals

Country

United States

Founded

2015
( 9 years old in 2024 )

Company Focus

Drug Substance

Website

-

Corporate Office and Headquarter Office address:

Philadelphia, PA
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developermanufacturercerebral vasospasmsubarachnoid hemorrhageits short-live psychotropic effect

* We use standard office opening hours in near Neurokappa Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Neurokappa Therapeutics Frequently Asked Questions

What or who is Neurokappa Therapeutics?

Neurokappa Therapeutics is Pharmaceuticals business from United States that founded in 2015 (9 years old in 2024), Neurokappa Therapeutics business is focusing on Drug Substance.

Where is Neurokappa Therapeutics headquarter and corporate office address?

Neurokappa Therapeutics headquarter office and corporate office address is located in Philadelphia, PA United States.

Where is Neurokappa Therapeutics country origins?

Neurokappa Therapeutics was founded in United States.

What is Drug Substance business focus on?

In 2024, Neurokappa Therapeutics is currently focus on drug substance sector.

Drug Substance Business Interest from Google Trend

Above is snippet of Google Trends for "drug substance" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Neurokappa Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.